Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules-Reference-Cited by-同舟云学术

Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules

Published:2007-12-29 Issue:1 Volume:19 Page:235-243
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Ahlgren Sara¹,Orlova Anna¹,Rosik Daniel¹,Sandström Mattias¹,Sjöberg Anna¹,Baastrup Barbro¹,Widmark Olof¹,Fant Gunilla¹,Feldwisch Joachim¹,Tolmachev Vladimir¹

Affiliation:

1. Division of Nuclear Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, Affibody AB, Bromma, Sweden, Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden, Hospital Physics, Department of Oncology, Uppsala University Hospital, Uppsala, Sweden

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc700307y

Reference34 articles.

1. 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

2. Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations

3. Trastuzumab and Breast Cancer

4. Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

5. Affibody molecules: potential forin vivoimaging of molecular targets for cancer therapy

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Affibody Molecules for PET Imaging;Methods in Molecular Biology;2023-11-26

2. Site-specific bioorthogonal protein labelling by tetrazine ligation using endogenous β-amino acid dienophiles;Nature Chemistry;2023-07-03

3. Antibodies as Vectors for Radiopharmaceutical Therapy;Radiopharmaceutical Therapy;2023

4. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer;Frontiers in Oncology;2022-06-15

5. Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2;Pharmaceutics;2022-02-26